Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304707 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence
A Phase 3 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 3
- Development phase
- 143
- Enrollment target
NCT00304707 is a Phase 3 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 143 participants.
The verdict
NCT00304707, a Phase 3 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 143 participants
- Enrollment target
Study Summary
Smoking is often a problem for alcohol dependent individuals. Many people who seek treatment for alcohol dependence are unable to quit smoking. The purpose of this study is to evaluate the effectiveness of bupropion, an antidepressant medication, in treating smokers receiving treatment for alcohol dependence.
Interventions
- DRUG placebo
- DRUG Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304707
The ClinicalTrials.gov registry entry for NCT00304707 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00304707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304707 about?
NCT00304707 is a clinical study titled "Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence". Smoking is often a problem for alcohol dependent individuals. Many people who seek treatment for alcohol dependence are unable to quit smoking. The purpose of this study is to evaluate the effectiveness of bupropion, an antidepressant medication, in treating smokers receiving treatment for alcohol d...
What is the current status of trial NCT00304707?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 143 participants. The study started on 2005-04. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00304707?
The interventions under investigation include: placebo (DRUG), Bupropion (DRUG).
Who is sponsoring clinical trial NCT00304707?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.